Clinical Trial Update: The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating the effects of Allicor on patients after coronary revascularization procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Coronary Artery Bypass Grafting
• Myocardial Ischemia
• Percutaneous Coronary Revascularization

Drugs mentioned

• Allicor

Snippet

Sponsor: Institute for Atherosclerosis Research, Russia | Conditions: Myocardial Ischemia, Coronary Artery Bypass Grafting | Phase 4 | Status: UNKNOWN